Despite the involvement of major arteries in pancreatic cancer, pancreatectomy with arterial resection (AR) following neoadjuvant therapy (NAT) can potentially enhance survival rates. A systematic review and meta-analysis of nine retrospective studies, with a total sample size of 215, showed that pancreatectomy with AR achieved an overall R0 resection rate of 79%. The median 1-, 2-, 3-, and 5-year survival rates were 92.3%, 64.8%, 51.6%, and 14%, respectively. However, prospective controlled studies are needed to validate these findings and address potential biases and limitations in current retrospective studies.
Journal Article by Xue K, Huang X (…) Tian B et 2 al. in Int J Surg
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.